Antibiotic-resistant genes and bacteria as evolving contaminants of emerging concerns (e-CEC): is it time to include evolution in risk assessment?
Article
Vassallo, A., Kett, S., Purchase, D. and Marvasi, M. 2021. Antibiotic-resistant genes and bacteria as evolving contaminants of emerging concerns (e-CEC): is it time to include evolution in risk assessment? Antibiotics. 10 (9), pp. 1-11. https://doi.org/10.3390/antibiotics10091066
Type | Article |
---|---|
Title | Antibiotic-resistant genes and bacteria as evolving contaminants of emerging concerns (e-CEC): is it time to include evolution in risk assessment? |
Authors | Vassallo, A., Kett, S., Purchase, D. and Marvasi, M. |
Abstract | The pressing issue of the abundance of antibiotic resistance genes and resistant bacteria in the environment (ARGs and ARB, respectively) requires procedures for assessing the risk to health. The chemo-centric environmental risk assessment models identify hazard(s) in a dose–response manner, obtaining exposure, toxicity, risk, impact and policy. However, this risk assessment approach based on ARGs/ARB evaluation from a quantitative viewpoint shows high unpredictability because ARGs/ARB cannot be considered as standard hazardous molecules: ARB duplicate and ARGs evolve within a biological host. ARGs/ARB are currently listed as Contaminants of Emerging Concern (CEC). In light of such characteristics, we propose to define ARGs/ARB within a new category of evolving CEC (or e-CEC). ARGs/ARB, like any other evolving determinants (e.g., viruses, bacteria, genes), escape environmental controls. When they do so, just one molecule left remaining at a control point can form the origin of a new dangerous and selection-responsive population. As a consequence, perhaps it is time to acknowledge this trait and to include evolutionary concepts within modern risk assessment of e-CEC. In this perspective we analyze the evolutionary responses most likely to influence risk assessment, and we speculate on the means by which current methods could measure evolution. Further work is required to implement and exploit such experimental procedures in future risk assessment protocols. |
Keywords | ARGs; ARB; antibiotics; antibiotic resistances; risk assessment; evolution |
Publisher | MDPI AG |
Journal | Antibiotics |
ISSN | 2079-6382 |
Publication dates | |
Online | 03 Sep 2021 |
03 Sep 2021 | |
Publication process dates | |
Deposited | 06 Sep 2021 |
Accepted | 31 Aug 2021 |
Submitted | 03 Aug 2021 |
Output status | Published |
Publisher's version | License |
Copyright Statement | © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
Digital Object Identifier (DOI) | https://doi.org/10.3390/antibiotics10091066 |
PubMed ID | 34572648 |
PubMed Central ID | 8469798 |
Web of Science identifier | WOS:000699170900001 |
Language | English |
https://repository.mdx.ac.uk/item/89781
Download files
65
total views15
total downloads2
views this month1
downloads this month